Hancock Whitney’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-5,299
| Closed | -$316K | – | 634 |
|
|
2024
Q3 | $316K | Buy |
5,299
+80
| +2% | +$4.77K | 0.01% | 525 |
|
|
2024
Q2 | $332K | Buy |
5,219
+7
| +0.1% | +$446 | 0.01% | 494 |
|
|
2024
Q1 | $360K | Buy |
+5,212
| New | +$360K | 0.01% | 507 |
|
|
2020
Q2 | – | Sell |
-8,083
| Closed | -$329K | – | 785 |
|
|
2020
Q1 | $329K | Buy |
8,083
+1,955
| +32% | +$79.6K | 0.01% | 604 |
|
|
2019
Q4 | $378K | Sell |
6,128
-3,918
| -39% | -$242K | 0.01% | 620 |
|
|
2019
Q3 | $732K | Sell |
10,046
-1,400
| -12% | -$102K | 0.02% | 506 |
|
|
2019
Q2 | $941K | Buy |
11,446
+155
| +1% | +$12.7K | 0.03% | 470 |
|
|
2019
Q1 | $796K | Buy |
11,291
+2,400
| +27% | +$169K | 0.03% | 519 |
|
|
2018
Q4 | $401K | Sell |
8,891
-2,179
| -20% | -$98.3K | 0.01% | 649 |
|
|
2018
Q3 | $626K | Sell |
11,070
-1,142
| -9% | -$64.6K | 0.02% | 596 |
|
|
2018
Q2 | $816K | Buy |
+12,212
| New | +$816K | 0.04% | 373 |
|